Zucker, Lynne; Darby, Michael R. - National Bureau of Economic Research (NBER) - 2002
Scientist-entrepreneurs prominent in biotech and other high-technology industries view going public not as a cost-effective source of capital but as a cross between selling a now-proven innovation and winning a lottery. Unlike most empirical IPO analyses confined to those firms that go public,...